| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |